Showing all 12 results

Show sidebar
Show 9 12 18 24
Compare

Crysvita

£4,071.01 – £10,926.90
Crysvita (burosumab) is indicated for the treatment of X-linked hypophosphatemia (XLH) and Tumor-induced osteomalacia (TIO).
Add to wishlist
Select options
Quick view
Compare

Evkeeza (evinacumab)

Evkeeza (evinacumab) is an injectable medicine used together with other low-density lipoprotein (LDL)-lowering medicines in people aged 12 years and older with a type of high cholesterol called Homozygous Familial Hypercholesterolemia (HoFH).
Add to wishlist
Price available on request
Quick view
Compare

Isturisa (osilodrostat)

£2,223.26 – £9,135.04
Isturisa (osilodrostat) is a medication used for the treatment of adult patients with Cushing’s syndrome or for adults with Cushing’s disease who are not candidates for surgery, or who did not respond to prior surgery.
Add to wishlist
Select options
Quick view
Compare

Kerendia (finerenone)

£756.04 – £2,268.12
Kerendia (finerenone) is a prescription medicine used to reduce the risk of kidney function decline, kidney failure, cardiovascular death, nonfatal heart attacks and hospitalization for heart failure in patients with chronic kidney disease associated with type 2 diabetes...
Add to wishlist
Select options
Quick view
Compare

Leqvio (inclisiran)

£3,262.55
Leqvio (inclisiran) is a medication used to reduce cholesterol levels in adults with primary hypercholesterolaemia or mixed dyslipidaemia.
Add to wishlist
Select options
Quick view
Compare

Oxlumo (lumasiran)

£78,304.12
Oxlumo (lumasiran) is a medication used to lower urinary oxalate levels in children and adults with primary hyperoxaluria type 1 (PH1). It is the first-ever therapy available for the treatment of patients with PH1. NOTE: This medicine can only be purchased on behalf of a hospital. Additional documents may be required. Please contact us for details.
Add to wishlist
Select options
Quick view
Compare

Palynziq (pegvaliase-pqpz)

£393.61 – £3,761.67
Palynziq (pegvaliase-pqpz) is indicated for the treatment of phenylketonuria (PKU), to reduce blood phenylalanine concentrations in adult and adolescent patients from 16 years of age who have uncontrolled blood phenylalanine concentrations greater than 600 micromol/L on existing management.
Add to wishlist
Select options
Quick view
Compare

Roszet (rosuvastatin and ezetimibe)

Roszet (rosuvastatin and ezetimibe) is a prescription medicine used in adults with high cholesterol levels to reduce low density lipoprotein cholesterol (LDL-C) or bad cholesterol.
Add to wishlist
Price available on request
Quick view
Compare

Vascepa (icosapent ethyl)

£648.00 – £672.18
Vascepa (icosapent ethyl) is a prescription medicine used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia and as an adjunct to statin therapy to reduce the risk of of cardiovascular events.
Add to wishlist
Select options
Quick view
Compare

Waylivra (volanesorsen)

£14,122.19
Waylivra (volanesorsen) is indicated as an adjunct to diet in adult patients with genetically confirmed familial chylomicronemia syndrome (FCS) and at high risk for pancreatitis, in whom response to diet and plasma triglycerides lowering therapy has been inadequate.
Add to wishlist
Select options
Quick view
Compare

Zegalogue (dasiglucagon)

£382.33 – £977.17
Zegalogue (dasiglucagon) is a rescue treatment used for severe low blood sugar (hypoglycemia) in people with diabetes.
Add to wishlist
Select options
Quick view
Compare

Zokinvy (lonafarnib)

£38,350.96 – £57,442.35
Zokinvy (lonafarnib) is a medication used to reduce the risk of death due to Hutchinson-Gilford progeria syndrome (HGPS) or certain types of Progeroid Laminopathies in patients one year of age and older. It is the first FDA-approved medication for these diseases.
Add to wishlist
Select options
Quick view